Zhao C, Lin S
Front Immunol. 2025; 15():1507065.
PMID: 39840043
PMC: 11747037.
DOI: 10.3389/fimmu.2024.1507065.
He R, Liu Y, Fu W, He X, Liu S, Xiao D
Mol Cancer. 2024; 23(1):267.
PMID: 39614268
PMC: 11606237.
DOI: 10.1186/s12943-024-02172-y.
Liebing E, Krug S, Neurath M, Siegmund B, Becker C
Cell Mol Gastroenterol Hepatol. 2024; 19(2):101423.
PMID: 39461590
PMC: 11720114.
DOI: 10.1016/j.jcmgh.2024.101423.
Zhang W, Zhu C, Liao Y, Zhou M, Xu W, Zou Z
Cell Mol Biol Lett. 2024; 29(1):130.
PMID: 39379817
PMC: 11463096.
DOI: 10.1186/s11658-024-00646-x.
Song J, Yang H
Front Endocrinol (Lausanne). 2024; 15:1449668.
PMID: 39351539
PMC: 11439655.
DOI: 10.3389/fendo.2024.1449668.
Influenza A virus infection activates caspase-8 to enhance innate antiviral immunity by cleaving CYLD and blocking TAK1 and RIG-I deubiquitination.
Yu H, Sun Y, Zhang J, Zhang W, Liu W, Liu P
Cell Mol Life Sci. 2024; 81(1):355.
PMID: 39158695
PMC: 11335283.
DOI: 10.1007/s00018-024-05392-z.
N4BP1 coordinates ubiquitin-dependent crosstalk within the IκB kinase family to limit Toll-like receptor signaling and inflammation.
Gitlin A, Maltzman A, Kanno Y, Heger K, Reja R, Schubert A
Immunity. 2024; 57(5):973-986.e7.
PMID: 38697117
PMC: 11096006.
DOI: 10.1016/j.immuni.2024.04.004.
Infections in Disorders of Immune Regulation.
Thangaraj A, Tyagi R, Suri D, Gupta S
Pathogens. 2024; 13(3).
PMID: 38535602
PMC: 10976012.
DOI: 10.3390/pathogens13030259.
PANoptosis in cancer, the triangle of cell death.
Cai H, Lv M, Wang T
Cancer Med. 2023; 12(24):22206-22223.
PMID: 38069556
PMC: 10757109.
DOI: 10.1002/cam4.6803.
Too much of a good thing: a review of primary immune regulatory disorders.
Tsilifis C, Slatter M, Gennery A
Front Immunol. 2023; 14:1279201.
PMID: 38022498
PMC: 10645063.
DOI: 10.3389/fimmu.2023.1279201.
ZBP1 Drives IAV-Induced NLRP3 Inflammasome Activation and Lytic Cell Death, PANoptosis, Independent of the Necroptosis Executioner MLKL.
Malireddi R, Sharma B, Bynigeri R, Wang Y, Lu J, Kanneganti T
Viruses. 2023; 15(11).
PMID: 38005819
PMC: 10674287.
DOI: 10.3390/v15112141.
Autoimmune lymphoproliferative immunodeficiencies (ALPIDs): A proposed approach to redefining ALPS and other lymphoproliferative immune disorders.
Magerus A, Rensing-Ehl A, Rao V, Teachey D, Rieux-Laucat F, Ehl S
J Allergy Clin Immunol. 2023; 153(1):67-76.
PMID: 37977527
PMC: 10841637.
DOI: 10.1016/j.jaci.2023.11.004.
Breaking bad: necroptosis in the pathogenesis of gastrointestinal diseases.
Patankar J, Bubeck M, Gonzalez Acera M, Becker C
Front Immunol. 2023; 14:1203903.
PMID: 37409125
PMC: 10318896.
DOI: 10.3389/fimmu.2023.1203903.
Caspase-8 inhibition improves the outcome of bacterial infections in mice by promoting neutrophil activation.
Lentini G, Fama A, De Gaetano G, Coppolino F, Mahjoub A, Ryan L
Cell Rep Med. 2023; 4(7):101098.
PMID: 37390829
PMC: 10394171.
DOI: 10.1016/j.xcrm.2023.101098.
Apoptotic cell death in disease-Current understanding of the NCCD 2023.
Vitale I, Pietrocola F, Guilbaud E, Aaronson S, Abrams J, Adam D
Cell Death Differ. 2023; 30(5):1097-1154.
PMID: 37100955
PMC: 10130819.
DOI: 10.1038/s41418-023-01153-w.
A rare immunological disease, caspase 8 deficiency: case report and literature review.
Bazgir N, Tahvildari A, Chavoshzade Z, Jamee M, Golchehre Z, Karimi A
Allergy Asthma Clin Immunol. 2023; 19(1):29.
PMID: 37038193
PMC: 10084589.
DOI: 10.1186/s13223-023-00778-3.
An IBD-associated pathobiont synergises with NSAID to promote colitis which is blocked by NLRP3 inflammasome and Caspase-8 inhibitors.
Singh R, Rossini V, Stockdale S, Saiz-Gonzalo G, Hanrahan N, D Souza T
Gut Microbes. 2023; 15(1):2163838.
PMID: 36656595
PMC: 9858430.
DOI: 10.1080/19490976.2022.2163838.
Tumor necrosis factor is a necroptosis-associated alarmin.
Pinci F, Gaidt M, Jung C, Nagl D, Kuut G, Hornung V
Front Immunol. 2022; 13:1074440.
PMID: 36578489
PMC: 9791252.
DOI: 10.3389/fimmu.2022.1074440.
Bidirectional Mendelian Randomisation Analysis Provides Evidence for the Causal Involvement of Dysregulation of CXCL9, CCL11 and CASP8 in the Pathogenesis of Ulcerative Colitis.
Chen J, Zhou Y, Sun Y, Yuan S, Kalla R, Sun J
J Crohns Colitis. 2022; 17(5):777-785.
PMID: 36576886
PMC: 10155748.
DOI: 10.1093/ecco-jcc/jjac191.
Dysregulated inflammasome activity in intestinal inflammation - Insights from patients with very early onset IBD.
Illig D, Kotlarz D
Front Immunol. 2022; 13:1027289.
PMID: 36524121
PMC: 9744759.
DOI: 10.3389/fimmu.2022.1027289.
